Clinical and pathophysiological relations between migraine and mood disorders

Current Psychiatry Reviews

Volumn 5, Issue 2, 2009, Pages 93-109

  Fasmer, Ole Bernt ^a,b   Akiskal, Hagop S ^c,d   Kelsoe, John R ^c,d   Oedegaard, Ketil J ^a,b,d  

^a UNIVERSITY OF BERGEN   (Norway)

^b HAUKELAND UNIVERSITY HOSPITAL   (Norway)

^c VA SAN DIEGO HEALTHCARE SYSTEM   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Bipolar disorder; Depression; Migraine; Pathophysiology

Indexed keywords

(3 CHLOROPHENYL)PIPERAZINE; 5,10 METHYLENETETRAHYDROFOLATE REDUCTASE (FADH2); AMFEBUTAMONE; AMITRIPTYLINE; AMPHETAMINE DERIVATIVE; ANTIDEPRESSANT AGENT; ATP1A2 PROTEIN; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BROMOCRIPTINE; CARBAMAZEPINE; DOPAMINE; ERGOTAMINE; GENE PRODUCT; GLUTAMIC ACID; LITHIUM SALT; POTASSIUM; PROTEIN CACNA1A; PROTEIN DRD2; PROTEIN SCN1A; RIBOFLAVIN; SEROTONIN; SEROTONIN 1D AGONIST; SEROTONIN AGONIST; SODIUM CHANNEL; SUMATRIPTAN; TRIPTAN DERIVATIVE; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; VALPROIC ACID; VOLTAGE GATED CALCIUM CHANNEL;

AGORAPHOBIA; ANOREXIA NERVOSA; ANXIETY DISORDER; ASTHMA; AUTONOMIC DYSFUNCTION; AUTONOMIC NERVOUS SYSTEM; BIPOLAR DISORDER; BRAIN FUNCTION; BULIMIA; CARDIOVASCULAR DISEASE; COMORBIDITY; DEPRESSION; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; DISEASE CLASSIFICATION; DISEASE DURATION; DISEASE SEVERITY; EATING DISORDER; ELECTROPHYSIOLOGY; ENERGY METABOLISM; EPILEPSY; FAMILIAL HEMIPLEGIC MIGRAINE; FAMILIAL HEMIPLEGIC MIGRAINE TYPE 1; FAMILIAL HEMIPLEGIC MIGRAINE TYPE 2; FAMILIAL HEMIPLEGIC MIGRAINE TYPE 3; GASTROINTESTINAL DISEASE; GENETICS; HABITUATION; HEADACHE; HEART RATE VARIABILITY; HEMISPHERIC DOMINANCE; HOSPITAL ANXIETY AND DEPRESSION SCALE; HUMAN; HYPERTENSION; IMAGE ANALYSIS; IMPULSE CONTROL DISORDER; INFLAMMATION; INTERNATIONAL CLASSIFICATION OF DISEASES; ION TRANSPORT; ISCHEMIC HEART DISEASE; LEFT HANDEDNESS; MAJOR DEPRESSION; MIGRAINE; MIGRAINE WITH AURA; MIGRAINE WITHOUT AURA; MOOD DISORDER; MOTOR DYSFUNCTION; NERVE CELL EXCITABILITY; NEUROLOGIC DISEASE; NEUROTRANSMISSION; NONHUMAN; ONSET AGE; PAIN; PANIC; PATHOPHYSIOLOGY; PREVALENCE; PRIORITY JOURNAL; REVIEW; RIGHT HANDEDNESS; SEX DIFFERENCE; SLEEP DISORDER; SPREADING CORTICAL DEPRESSION; SUICIDAL BEHAVIOR; SYMPTOMATOLOGY; VAGUS NERVE;

EID: 70350304394     PISSN: 15734005     EISSN: None     Source Type: Journal    
DOI: 10.2174/157340009788167365     Document Type: Review

References (250)

1. Alonso J, Angermeyer MC, Bernert S, et al. Prevalence of mental disorders in Europe: results from the European Study of the Epidemiology of Mental Disorders (ESEMeD) project. Acta Psychiatr Scand (Suppl.) 2004; 420: 21-7.
2. Scher AI, Stewart WF, Lipton RB. Migraine and Headache: A meta-analytic approach. In: Crombie IK, Croft PR, Linton SJ, LeResche L, Von Korff M, Ed, Epidemiology of pain. Seattle, IASP Press 1999; 159-70.
3. Fasmer OB, Oedegaard KJ. Clinical characteristics of patients with major affective disorders and comorbid migraine. World J Biol Psychiatry 2001; 2: 149-55.
4. Davidoff RA. Migraine: manifestations, pathogenesis, and management. New York, Oxford University Press 2002.
5. Silberstein SD, Goadsby PJ. Migraine: preventive treatment. Cephalalgia 2002; 22: 491-512.
6. Giffin NJ, Ruggiero L, Lipton RB, et al. A novel approach to the study of premonitory symptoms in migraine using an electronic diary. Neurology 2003; 60: 935-40.
7. Shankar DS, Sudhir K. Hypomania as an aura in migraine aura. Neurol India 2006; 54: 205-6.
8. Feely MP, O'Hare J, Veale D, Callaghan N. Episodes of acute confusion or psychosis in familial hemiplegic migraine. Acta Neurol Scand 1982; 65: 369-75
9. Spranger M, Schwab S, Benninger C, Dichgans M. Familial hemiplegic migraine with cerebellar ataxia and paroxysmal psychosis. Eur Neurol 1999; 41: 150-2.
10. Meyer JS, Thornby J, Crawford K, Rauch GM. Reversible cognitive decline accompanies migraine and cluster headaches. Headache 2000; 40: 638-46.
11. Calandre EP, Bembibre J, Arnedo ML, Becerra D. Cognitive disturbances and regional cerebral blood flow abnormalities in migraine patients: their relationship with the clinical manifestations of the illness. javascript: AL_get(this, 'jour', 'Cephalalgia.'); Cephalalgia 2002; 22: 291-302
12. Fanciullaci C, Alessandri M, Fanciullacci M. The relationship between stress and migraine. Funct Neurol 1998; 3: 215-23.
13. Rasmussen BK. Epidemiology of headache. Cephalalgia 2001; 21: 774-7.
14. Rasmussen BK, Olesen J. Migraine with aura and migraine without aura: an epidemiological study. Cephalalgia 1992; 12: 221-8.
15. Fasmer OB, Oedegaard KJ. Co-morbidity of migraine and affective disorders. In: Brown MR Ed, Focus on Bipolar Disorder Research. New York, Nova Science 2005; 59-74.
16. Low NC, Du Fort GG, Cervantes P. Prevalence, clinical correlates, and treatment of migraine in bipolar disorder. Headache 2003; 43: 940-9.
17. Mahmood T, Romans S, Silverstone T. Prevalence of migraine in bipolar disorder. J Affect Disord 1999; 52: 239-41.
18. Oedegaard KJ, Angst J, Neckelmann D, Fasmer OB. Migraine aura without headache compared to migraine with aura in patients with affective disorders. J Headache Pain 2005; 378-86.
19. Headache Classification Committee. The International Classification of Headache Disorders, 2nd Ed. Cephalalgia 2004; 24: 1-160.
20. Breslau N, Rasmussen BK. The impact of migraine. Epidemiology, risk factors, and co- morbidities. Neurology 2001; 56 (Suppl 1): S4-S12.
21. Goodwin and Jamison. Manic-depressive illness. New York, Oxford University Press 2007.
22. Akiskal HS. The prevalent clinical spectrum of bipolar disorders: beyond DSM-IV. J Clin Psychopharmacol 1996; 16 (Suppl. 1): 4S-14S.
23. Kramlinger KG, Post RM. Ultra-rapid and ultradian cycling in bipolar affective illness. Br J Psychiatry 1996; 168: 314-23.
24. Guitera V, Munoz P, Castillo J, Pascual J. Transformed migraine: a proposal for the modification of its diagnostic criteria based on recent epidemiological data. Cephalalgia 1999; 19: 847-50.
25. Ossipova VV, Kolosova OA, Vein AM. Migraine associated with panic attacks. Cephalalgia 1999; 19: 728-31.
26. Haan J, Terwindt GM, van den Maagdenberg AMJM, Stam AH, Ferrari MD. A review of the genetic relation between migraine and epilepsy. Cephalalgia 2008; 28: 105-13.
27. Lipton RB, Stewart WF. Migraine headaches: epidemiology and comorbidity. Clin Neurosci 1998; 5: 2-9.
28. Leniger T, von den Driesch S, Isbruch K, Diener HC, Hufnagel A. Clinical characteristics of patients with comorbidity of migraine and epilepsy. Headache 2003; 43: 672-677.
29. Silberman EK, Post RM, Nurnberger J, Theodore W, Boulenger JP. Transient sensory, cognitive and affective phenomena in affective illness. A comparison with complex partial epilepsy. Br J Psychiatry 1985; 146: 81-9.
30. Wittchen HU. Critical issues in the evaluation of comorbidity of psychiatric disorders. Br J Psychiatry 1996; 30(Suppl.): 9-16.
31. Klein MH, Kupfer DJ, Shea MT. Personality and depression: a current view. New York, Guilford 1993.
32. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, 4th ed, rev (DSM IV). Washington DC, American Psychiatric Press 1994.
33. Merikangas KR, Angst J, Isler H. Migraine and psychopathology. Arch Gen Psychiatry 1990; 47: 849-53.
34. Zwart JA, Dyb G, Hagen K, et al. Anxiety and depression associated with headache frequency. Eur J Neurol 2003; 10: 147-52.
35. Breslau N, Davis GC. Migraine, physical health and psychiatric disorders: a prospective epidemiologic study in young adults. J Psychiatr Res 1993; 27: 211-21.
36. Swartz KL, Pratt LA, Armenian HK, Lee LC, Eaton WW. Mental disorders and the incidence of migraine headaches in community sample: results from the balitmore epidemiologic catchment area follow-up study. Arch Gen Psychiatry 2000; 57: 945-50.
37. Kececi H, Dener S, Analan E. Co-morbidity of migraine and major depression in the Turkish population. Cephalalgia 2003; 23: 271-5.
38. Breslau N, Schultz LR, Stewart WF, et al. Headache and major depression - Is the association specific to migraine? Neurology 2000; 54: 308-13.
39. Breslau N, Lipton RB, Stewart WF, Schultz LR, Welch KMA. Comorbidity of migraine and depression - Investigating potential etiology and prognosis. Neurology 2003; 60: 1308-12
40. Hirschfeld RM, Calabrese JR, Weissman MM, et al. Screening for bipolar disorder in the community. J Clin Psychiatry 2003; 64: 53-9.
41. Fasmer OB. The prevalence of migraine in patients with bipolar and unipolar affective disorders. Cephalalgia 2001; 21: 894-9.
42. Dilsaver SD, Benazzi F, Oedegaard KJ, Fasmer OB, Akiskal KK, Akiskal HS. Is a family history of bipolar disorder a risk factor for migraine? Psychopathology 2009; 42: 119-23.
43. Robbins L, Ludmer C. The bipolar spectrum in migraine patients. Am J Pain Manag 2000; 10: 167-170.
44. Endicott NA. Psychophysiological correlates of "bipolarity". J Affect Disord 1989; 17: 47-56.
45. Radat F, Swendsen J. Psychiatric comorbidity in migraine: a review. Cephalalgia 2005; 25: 165-78.
46. Merikangas KR, Stevens DE. Comorbidity of migraine and psychiatric disorders. Neurol Clin 1997; 15: 115-23.
47. Merikangas KR, Merikangas JR, Angst J. Headache syndromes and psychiatric disorders: association and familial transmission. J Psychiatr Res 1993; 27: 197-210.
48. Fasmer OB, Oedegaard KJ. Are migraines and bipolar disorder related? Psychiatric Times 2002; 19: 48-51.
49. Weissman MM, Gross R, Fyer A, Heiman GA, et al. Interstitial cystitis and panic disorder: a potential genetic syndrome. Arch Gen Psychiatry 2004; 61: 273-9.
50. Marazziti D, Toni C, Pedri S, et al. Prevalence of headache syndromes in panic disorder. Int Clin Psychopharmacol 1999; 14: 247-51.
51. Akiskal HS, Mallya G. Criteria for the "soft" bipolar spectrum: treatment implications. Psychopharmacol Bull 1987; 23: 68-73.
52. Akiskal HS, Akiskal K. Cyclothymic, hyperthymic and depressive temperaments as affective variants of mood disorders. In: Tasman A, Riba MB, Eds, Annual Review of Psychiatry, vol 11, Washington DC, American Psyciatric Press 1992; 43-62.
53. Akiskal HS, Akiskal KK, Haykal RF, Manning JS, Connor PD. TEMPS-A: progress towards validation of a self-rated clinical version of the Temperament evaluation of the Memphis, Pisa, Paris, and San Diego autoquestionnaire. J Affect Disord 2005; 85: 3-16.
54. Wolff HG. Personality features and reactions of subjects with migraine. Arch Neurol Psychiatry 1937; 37: 895-921.
55. Akiskal HS, Maser JD, Zeller PJ, et al. Switching from 'unipolar' to bipolar II. An 11-year prospective study of clinical and temperamental predictors in 559 patients. Arch Gen Psychiatry 1995; 52: 114-23.
56. Oedegaard KJ, Fasmer OB. Is migraine in unipolar depressed patients a bipolar spectrum trait? J Affect Disord 2004; 84: 233-42.
57. Breslau N, Davis GC, Andreski P. Migraine, psychiatric disorders, and suicide attempts: an epidemiologic study of young adults. Psychiatry Res 1991; 37: 11-23.
58. Breslau N. Migraine, suicidal ideation, and suicide attempts. Neurology 1992; 42: 392-5.
59. Wang SJ, Juang KD, Fuh JL, Lu SR. Psychiatric comorbidity and suicide risk in adolescents with chronic daily headache. Neurology 2007; 68: 1468-73.
60. Rihmer Z. Suicide risk in mood disorders. Curr Opin Psychiatry 2007; 20: 17-22.
61. Breslau N, Merikangas K, Bowden CL. Comorbidity of migraine and major affective disorders. Neurology 1994; 44 (suppl 7): S17-S22.
62. Oedegaard KJ, Neckelmann D, Mykletun A, et al. Migraine with and without aura: Association with depression and anxiety in a population-based study. The HUNT study. Cephalalgia 2006; 26: 1-6.
63. Silberstein SD, Merriam G. Sex hormones and headache (menstrual migraine). Neurology 1999; 53(Suppl 1): S3-S13.
64. Russel MB, Krogh Rasmussen B, Thorvaldsen P, Olesen J. Prevalence and sex-ratio of the subtypes of migraine. Int J Epidemiol 1995; 24: 612-8.
65. Roggenbach J, Muller-Oerlinghausen B, Franke L. Suicidality, impulsivity and aggression - is there a link to 5HIAA concentration in the cerebrospinal fluid? Psychiatry Res 2002; 113: 193-206.
66. Mahmood T, Silverstone T, Connor R, Herbison P. Sumatriptan challenge in bipolar patients with and without migraine: a neuroendocrine study of 5-HT1D receptor function. Int Clin Psychopharmacol 2002; 17: 33-6.
67. Trafford JC, Lafferty K, Potter CE, Roberts VC, Cotton LT. An epidemiological Survey of Raynaud's Phenomenon. Eur J Vasc Surg 1988; 2: 167-70.
68. Smyth AE, Hughes AE, Bruce IN, Bell AL. A case-control study of vasoactive mediator genes in primary Raynaud's phenomenon. Rheumatology 1999; 38: 1094-8.
69. Brewerton TD, George MS. Is migraine related to the eating disorders? Int J Eat Disord 1993; 14: 75-9.
70. McElroy SL, Pope HG Jr, Keck PE Jr, Hudson JI, Phillips KA, Strakowski SM. Are impulse-control disorders related to bipolar disorder? Compr Psychiatry 1996; 37: 229-40.
71. Perugi G, Akiskal HS. The soft bipolar spectrum redefined: focus on the cyclothymic, anxious-sensitive, impulse-dyscontrol, and binge-eating connection in bipolar II and related conditions. Psychiatr Clin North Am 2002; 25: 713-37.
72. Akiskal HS, Pinto O. The evolving bipolar spectrum: Prototypes I, II, III, IV. Psychiatr Clin North Am 1999; 22: 517-34.
73. Lara DR, Pinto O, Akiskal K, Akiskal HS. Toward an integrative model of the spectrum of mood, behavioral and personality disorders based on fear and anger traits: I. Clinical implications. J Affect Disord 2006; 94: 67-87.
74. McElroy SL, Soutullo CA, Beckman DA, Taylor P Jr, Keck PE Jr. DSM-IV intermittent explosive disorder: a report of 27 cases. J Clin Psychiatry 1998; 59: 203-10.
75. Osby U, Brandt L, Correia N, Ekbom A, Sparén P. Excess mortality in bipolar and unipolar disorder in Sweden. Arch Gen Psychiatry 2001; 58: 844-50.
76. Barrick CB. Sad, glad, or mad hearts? Epidemiological evidence for a causal relationship between mood disorders and coronary artery disease. J Affect Disord 1999; 53: 193-201.
77. Oedegaard KJ, Neckelmann D, Fasmer OB. Type A behaviour differentiates bipolar II from unipolar depressed patients. J Affect Disord 2006; 90: 7-13.
78. Low NC, Merikangas KR. The comorbidity of migraine. CNS Spectr 2003; 8: 433-4, 437-44.
79. Scher AI, Terwindt GM, Picavet HSJ, Verschuren WMM, Ferrari MD, Launer LJ. Cardiovascular risk factors and migraine - The GEM population-based study. Neurology 2005; 64: 614-620.
80. O'Keeffe ST, Tsapatsaris NP, Beetham WP. Association between Raynaud's phenomenon and migraine in a random population of hospital employees. J Rheumatol 1993; 20: 1187-8.
81. Barry JJ. The recognition and management of mood disorders as a comorbidity of epilepsy. Epilepsia 2003; 44 (Suppl 4): 30-40.
82. Hesdorffer DC, Lúdvígsson P, Hauser WA, Olafsson E, Kjartansson O. Co-occurrence of major depression or suicide attempt with migraine with aura and risk for unprovoked seizure. Epilepsy Res 2007; 75: 220-3.
83. Mrazek DA. Psychiatric symptoms in patients with asthma causality, comorbidity, or shared genetic etiology. Child Adolesc Psychiatr Clin N Am 2003; 12: 459-71.
84. Biary N, Koller W, Langenberg P. Correlation between essential tremor and migraine headache. J Neurol Neurosurg Psychiatry 1990; 53: 1060-2.
85. Barabas G, Matthews WS, Ferrari M. Tourette's syndrome and migraine. Arch Neurol 1984; 41: 871-2.
86. Kelman L, Rains JC Headache and sleep: examination of sleep patterns and complaints in a large clinical sample of migraineurs. Headache 2005; 45: 904-10.
87. Hughes JR. A review of sleepwalking (somnambulism): the enigma of neurophysiology and polysomnography with differential diagnosis of complex partial seizures. Epilepsy Behav 2007; 11: 483-91.
88. Bruder GE, Stewart JW, Towey JP, et al. Abnormal cerebral laterality in bipolar depression: convergence of behavioral and brain event-related potential findings. Biol Psychiatry 1992; 32: 33-47.
89. Koek RJ, Yerevanian BI, Tachiki KH, Smith JC, Alcock J, Kopelowicz A. Hemispheric asymmetry in depression and mania. A longitudinal QEEG study in bipolar disorder. J Affect Disord 1999; 53: 109-22.
90. David AS. Cutting JC. Affect, affective disorder and schizophrenia. A neuropsychological investigation of right hemisphere function. Br J Psychiatry 1990; 156: 491-5.
91. Morris PLP, Robinson RG, Raphael B, Hopwood MJ. Lesion location and poststroke depression. J Neuropsychiat Clin Neurosci 1996; 8: 399-403.
92. Defrance JF, Ginsberg LD, Rosenberg BA, Sharma JC. Topographical analysis of adolescent affective disorders. Int J Neurosci 1996; 86: 119-41.
93. Brandt JB, Celentano D, Stewart W, Linet M, Folstein MF. Personality and emotional disorder in a community sample of migraine headache sufferers. Am J Psychiatry 1990; 147: 303-8.
94. Olesen J. Some clinical features of the acute migraine attack. An analysis of 750 patients. Headache 1978; 18: 268-71.
95. Crisp AH. Laterality of migraine and reported affect. The relevance of an hypothesis concerning the nature of migraine. J Affect Disord 1981; 3: 71-5.
96. Crisp AH, Kamen J, Potamianos G, Bhat AV. Cerebral hemisphere function and laterality of migraine. Psychoter Psychosom 1985; 43: 49-55.
97. Fasmer OB, Oedegaard KJ. Laterality of pain in migraine with comorbid unipolar depressive and bipolar II disorders. Bipolar Disord 2002; 4: 290-5.
98. Geschwind N, Behan P. Left-handedness: association with immune disease, migraine, and developmental learning disorder. Proc Natl Acad Sci USA 1982; 79: 5097-100.
99. Messinger HB, Messinger MI, Graham JR. Migraine and left-handedness: is there a connection? Cephalalgia 1988; 8: 237-44.
100. Messinger HB, Messinger MI, Kudrow L, Kudrow LV. Handedness and headache. Cephalalgia 1994; 14: 64-7.
101. Hering R, 1995. Migraine, tension headache and left-handedness. Cephalalgia 1995; 15: 145-6.
102. Fasmer OB, Akiskal HS, Hugdahl K, Oedegaard KJ. Non-right handedness is associated with migraine and soft bipolarity in patients with mood disorders. J Affect Disord 2008; 108: 217-24.
103. Kilty T, Charney N, Leviton A, 1987. Headaches, performance in high school, and handedness. Percept Mot Skills 1987; 65: 159-63.
104. Endicott NA. Patterns of functional brain organization and migraine. Cephalalgia 2004; 24: 339-46.
105. Wessman M, Terwindt GM, Kaunisto MA, Palotie A, Ophoff RA. Migraine: a complex genetic disorder. Lancet Neurol 2007; 6: 521-32.
106. Askland K. Toward a biaxial model of "bipolar" affective disorders: Further exploration of genetic, molecular and cellular substrates. J Affect Disord 2006; 94: 35-66.
107. MacKinnon DF, Xu J, McMahon FJ, et al. Bipolar disorder and panic disorder in families: an analysis of chromosome 18 data. Am J Psychiatry 1998; 155: 829-31.
108. Anttila V, Kallela M, Oswell G, et al. A. Trait components provide tools to dissect the genetic susceptibility of migraine. Am J Hum Genet 2006; 79: 85-99.
109. Gardner K, Barmada MM, Ptacek LJ, Hoffman EP. A new locus for hemiplegic migraine maps to chromosome 1q31. Neurology 1997; 49: 1231-8.
110. Nyholt DR, Dawkins J, Brimage PJ, Goadsby PJ, Nicholson GA, Griffiths LR. Evidence for an X-linked genetic component in familial typical migraine. Hum Mol Genet 1998; 7: 459-63.
111. Nyholt DR, Lea RA, Goadsby PJ, Brimage PJ, Griffiths LR. Familial typical migraine: linkage to chromosome 19p13 and evidence for genetic heterogeneity. Neurology 1998; 50: 1428-32.
112. Nyholt DR, Curtain RP, Griffiths LR. Familial typical migraine: significant linkage and localization of a gene to Xq24-28. Hum Genet 2000; 107: 18-23.
113. Jones KW, Ehm MG, Pericak-Vance MA, Haines JL, Boyd PR, Peroutka SJ. Migraine with aura susceptibility locus on chromosome 19p13 is distinct from the familial hemiplegic migraine locus. Genomics 2001; 78: 150-4.
114. Carlsson A, Forsgren L, Nylander PO, et al. Identification of a susceptibility locus for migraine with and without aura on 6p12.2-p21.1. Neurology 2002; 59: 1804-7.
115. Wessman M, Kallela M, Kaunisto MA, et al. A susceptibility locus for migraine with aura, on chromosome 4q24. Am J Hum Genet 2002; 70: 652-62.
116. Lea RA, Shepherd AG, Curtain RP, et al. A typical migraine susceptibility region localizes to chromosome 1q31. Neurogenetics 2002; 4: 17-22.
117. Björnsson A, Gudmundsson G, Gudfinnsson E, et al. Localization of a gene for migraine without aura to chromosome 4q21. Am J Hum Genet 2003; 73: 986-93.
118. Soragna D, Vettori A, Carraro G, et al. A locus for migraine without aura maps on chromosome 14q21.2-q22.3. Am J Hum Genet 2003; 72: 161-7.
119. Cader ZM, Noble-Topham S, Dyment DA, et al. Significant linkage to migraine with aura on chromosome 11q24. Hum Mol Genet 2003; 12: 2511-7.
120. Nyholt DR, Morley KI, Ferreira MA, et al. Genomewide significant linkage to migrainous headache on chromosome 5q21. Am J Hum Genet 2005; 77: 500-12.
121. Russo L, Mariotti P, Sangiorgi E, et al. A new susceptibility locus for migraine with aura in the 15q11-q13 genomic region containing three GABA-A receptor genes. Am J Hum Genet 2005; 76: 327-33.
122. Lea RA, Nyholt DR, Curtain RP, et al. A genome-wide scan provides evidence for loci influencing a severe heritable form of common migraine. Neurogenetics 2005; 6: 67-72.
123. Detera-Wadleigh SD, Badner JA, Yoshikawa T, et al. Initial genome scan of the NIMH genetics initiative bipolar pedigrees: chromosomes 4, 7, 9, 18, 19, 20, and 21q. Am J Med Genet 1997; 74: 254-62.
124. Willour VL, Zandi PP, Huo Y, et al. Genome scan of the fifty-six bipolar pedigrees from the NIMH genetics initiative replication sample: chromosomes 4, 7, 9, 18, 19, 20, and 21. Am J Med Genet B Neuropsychiatr Genet 2003; 121B: 21-7.
125. Radhakrishna U, Senol S, Herken H, et al. An apparently dominant bipolar affective disorder (BPAD) locus on chromosome 20p11.2-q11.2 in a large Turkish pedigree. Eur J Hum Genet 2001; 1: 39-44.
126. Savitz J, Cupido CL, Ramesar RK. Preliminary evidence for linkage to chromosome 1q31-32, 10q23.3, and 16p13.3 in a South African cohort with bipolar disorder. Am J Med Genet B Neuropsychiatr Genet 2007; 144: 383-7.
127. Jamra R, Fuerst R, Kaneva R, et al. The first genomewide interaction and locus- heterogeneity linkage scan in bipolar affective disorder: strong evidence of epistatic effects between loci on chromosomes 2q and 6q. Am J Hum Genet 2007; 81: 974-86.
128. Zandi PP, Badner JA, Steele J, et al. Genome-wide linkage scan of 98 bipolar pedigrees and analysis of clinical covariates. Mol Psychiatry 2007; 12: 630-9.
129. Goes FS, Zandi PP, Miao K, et al. Mood-incongruent psychotic features in bipolar disorder: familial aggregation and suggestive linkage to 2p11-q14 and 13q21-33. Am J Psychiatry 2007; 164: 236-47.
130. Cassidy F, Zhao C, Badger J, et al. Genome-wide scan of bipolar disorder and investigation of population stratification effects on linkage: support for susceptibility loci at 4q21, 7q36, 9p21, 12q24, 14q24, and 16p13. Am J Med Genet B Neuropsychiatr Genet 2007; 144: 791-801.
131. Kerner B, Brugman DL, Freimer NB. Evidence of linkage to psychosis on chromosome 5q33-34 in pedigrees ascertained for bipolar disorder. Am J Med Genet B Neuropsychiatr Genet 2007; 144: 74-8.
132. Jones I, Hamshere M, Nangle JM, et al. Bipolar affective puerperal psychosis: genome- wide significant evidence for linkage to chromosome 16. Am J Psychiatry 2007; 164: 1099-104.
133. Etain B, Mathieu F, Rietschel M, et al. Genome-wide scan for genes involved in bipolar affective disorder in 70 European families ascertained through a bipolar type I early-onset proband: supportive evidence for linkage at 3p14. Mol Psychiatry 2006; 11: 685-94.
134. Marcheco-Teruel B, Flint TJ, Wikman FP, et al. A genome-wide linkage search for bipolar disorder susceptibility loci in a large and complex pedigree from the eastern part of Cuba. Am J Med Genet B Neuropsychiatr Genet 2006; 141: 833-43.
135. Tomàs C, Cañellas F, Rodríguez V, et al. Genetic linkage study for bipolar disorders on chromosomes 17 and 18 in families with a high expression of mental illness from the Balearic Islands. Psychiatr Genet 2006; 16: 145-51.
136. Mukherjee O, Meera P, Ghosh S, et al. Evidence of linkage and association on 18p11.2 for psychosis. Am J Med Genet B Neuropsychiatr Genet 2006; 141: 868-73.
137. Schumacher J, Kaneva R, Jamra RA, et al. Genomewide scan and fine-mapping linkage studies in four European samples with bipolar affective disorder suggest a new susceptibility locus on chromosome 1p35-p36 and provides further evidence of loci on chromosome 4q31 and 6q24. Am J Hum Genet 2005; 77: 1102-11.
138. Hamshere ML, Bennett P, Williams N, et al. Genomewide linkage scan in schizoaffective disorder: significant evidence for linkage at 1q42 close to DISC1, and suggestive evidence at 22q11 and 19p13. Arch Gen Psychiatry 2005; 62: 1081-8.
139. Lambert D, Middle F, Hamshere ML, et al. Stage 2 of the Wellcome Trust UK-Irish bipolar affective disorder sibling-pair genome screen: evidence for linkage on chromosomes 6q16-q21, 4q12-q21, 9p21, 10p14-p12 and 18q22. Mol Psychiatry 2005; 10: 831-41.
140. McQueen MB, Devlin B, Faraone SV, et al. Combined analysis from eleven linkage studies of bipolar disorder provides strong evidence of susceptibility loci on chromosomes 6q and 8q. Am J Hum Genet 2005; 77: 582-95.
141. Kealey C, Roche S, Claffey E, McKeon P. Linkage and candidate gene analysis of 14q22-24 in bipolar disorder: support for GCHI as a novel susceptibility gene. Am J Med Genet B Neuropsychiatr Genet 2005; 136: 75-80.
142. Lin PI, McInnis MG, Potash JB, et al. Assessment of the effect of age at onset on linkage to bipolar disorder: evidence on chromosomes 18p and 21q. Am J Hum Genet 2005; 77: 545-55.
143. Macgregor S, Visscher PM, Knott SA, et al. A genome scan and follow-up study identify a bipolar disorder susceptibility locus on chromosome 1q42. Mol Psychiatry 2004; 12: 1083-90.
144. Middleton FA, Pato MT, Gentile KL, et al. Genomewide linkage analysis of bipolar disorder by use of a high-density single-nucleotide-polymorphism (SNP) genotyping assay: a comparison with microsatellite marker assays and finding of significant linkage to chromosome 6q22. Am J Hum Genet 2004; 74: 886-97.
145. Fallin MD, Lasseter VK, Wolyniec PS et al. Genomewide linkage scan for bipolar-disorder susceptibility loci among Ashkenazi Jewish families. Am J Hum Genet 2004; 75: 204-19.
146. Curtis D, Kalsi G, Brynjolfsson J, et al. Genome scan of pedigrees multiply affected with bipolar disorder provides further support for the presence of a susceptibility locus on chromosome 12q23-q24, and suggests the presence of additional loci on 1p and 1q. Psychiatr Genet 2003; 13: 77-84.
147. McInnis MG, Dick DM, Willour VL, et al. Genome-wide scan and conditional analysis in bipolar disorder: evidence for genomic interaction in the National Institute of Mental Health genetics initiative bipolar pedigrees. Biol Psychiatry 2003; 54: 1265-73.
148. Ewald H, Kruse TA, Mors O. Genome wide scan using homozy-gosity mapping and linkage analyses of a single pedigree with affective disorder suggests oligogenic inheritance. Am J Med Genet B Neuropsychiatr Genet 2003; 120: 63-71.
149. Ekholm JM, Kieseppä T, Hiekkalinna T, et al. Evidence of susceptibility loci on 4q32 and 16p12 for bipolar disorder. Hum Mol Genet 2003; 12: 1907-15.
150. Ewald H, Flint T, Kruse TA, Mors O. A genome-wide scan shows significant linkage between bipolar disorder and chromosome 12q24.3 and suggestive linkage to chromosomes 1p22-21, 4p16, 6q14-22, 10q26 and 16p13.3. Mol Psychiatry 2002; 7: 734-44.
151. Ekholm JM, Pekkarinen P, Pajukanta P, et al. Bipolar disorder susceptibility region on Xq24-q27.1 in Finnish families. Mol Psychiatry 2002; 7: 453-9.
152. Bailer U, Leisch F, Meszaros K, et al. Genome scan for susceptibility loci for schizophrenia and bipolar disorder. Biol Psychiatry 2002; 52: 40-52.
153. Dick DM, Foroud T, Edenberg HJ, et al. Apparent replication of suggestive linkage on chromosome 16 in the NIMH genetics initiative bipolar pedigrees. Am J Med Genet 2002; 114: 407-12.
154. Cichon S, Schumacher J, Müller DJ, et al. A genome screen for genes predisposing to bipolar affective disorder detects a new susceptibility locus on 8q. Hum Mol Genet 2001; 10: 2933-44.
155. Kelsoe JR, Spence MA, Loetscher E, et al. A genome survey indicates a possible susceptibility locus for bipolar disorder on chromosome 22. Proc Natl Acad Sci USA 2001; 98: 585-90.
156. Detera-Wadleigh SD, Badner JA, Berrettini WH, et al. A high-density genome scan detects evidence for a bipolar-disorder susceptibility locus on 13q32 and other potential loci on 1q32 and 18p11.2. Proc Natl Acad Sci USA 1999; 96: 5604-9.
157. Morissette J, Villeneuve A, Bordeleau L, et al. Genome-wide search for linkage of bipolar affective disorders in a very large pedigree derived from a homogeneous population in quebec points to a locus of major effect on chromosome 12q23-q24. Am J Med Genet 1999; 88: 567-87.
158. Ginns EI, St Jean P, Philibert RA, et al. A genome-wide search for chromosomal loci linked to mental health wellness in relatives at high risk for bipolar affective disorder among the old order amish. Proc Natl Acad Sci USA 1998; 95: 15531-6.
159. Ewald H, Degn B, Mors O, Kruse TA. Support for the possible locus on chromosome 4p16 for bipolar affective disorder. Mol Psychiatry 1998; 5: 442-8.
160. Edenberg HJ, Foroud T, Conneally PM, et al. Initial genomic scan of the NIMH genetics initiative bipolar pedigrees: chromosomes 3, 5, 15, 16, 17, and 22. Am J Med Genet 1997; 74: 238-46.
161. Blackwood DH, He L, Morris SW, et al. A locus for bipolar affective disorder on chromosome 4p. Nat Genet 1996; 4: 427-30.
162. Turecki G, Smith M, Mari JJ. Type I bipolar disorder associated with a fragile site on chromosome 1. Am J Med Genet 1995; 60: 179-82.
163. Pekkarinen P, Terwilliger J, Bredbacka PE, Lönnqvist J, Peltonen L. Evidence of a predisposing locus to bipolar disorder on Xq24-q27.1 in an extended Finnish pedigree. Genome Res 1995; 5: 105-15.
164. Thomsen LL, Eriksen MK, Romer SF, et al. An epidemiological survey of hemiple gic migraine. Cephalalgia 2002: 22: 361-75.
165. Pietrobon D. Familial hemiplegic migraine. Neurotherapeutics 2007; 4: 274-84.
166. Moskowitz MA, Bolay H, Dalkara T. Deciphering migraine mechanisms: Clues from familial hemiplegic migraine genotypes. Ann Neurol 2004; 55: 276-80.
167. van de Ven RC, Kaja S, Plomp JJ, Frants RR, van den Maagdenberg AM, Ferrari MD. Genetic models of migraine. Arch Neurol 2007; 64: 643-6.
168. Colson NJ, Fernandez F, Lea RA, Griffiths LR. The search for migraine genes: an overview of current knowledge. Cell Mol Life Sci 2007; 64: 331-44.
169. Mahmood T, Silverstone T. Serotonin and bipolar disorder. J Affect Disord 2001; 66: 1-11.
170. Bhagwagar Z, Whale R, Cowen PJ. State and trait abnormalities in serotonin function in major depression. Br J Psychiatry 2002; 180: 24-8.
171. Mann JJ, Malone KM, Diehl DJ, Perel J, Cooper TB, Mintun MA. Demonstration in vivo of reduced serotonin responsivity in the brain of untreated depressed patients. Am J Psychiatry 1996; 153: 174-82.
172. Apter A, van Praag HM, Plutchik R, Sevy S, Korn M, Brown SL. Interrelationships among anxiety, aggression, impulsivity, and mood: a serotonergically linked cluster? Psychiatry Res 1990; 32: 191-9.
173. Stein DJ, Stahl S. Serotonin and anxiety: current models. Int Clin Psychopharmacol 2000; 15 (Suppl 2): S1-6.
174. Silberstein SD. Serotonin (5-HT) and migraine. Headache 1994; 34: 408-17.
175. Hargreaves RJ, Shepheard SL. Pathophysiology of migraine - new insights. Can J Neurol Sci 1999; 26 (Suppl 3): S12-9.
176. Wang W, Timsit-Berthier M, Schoenen J. Intensity dependence of auditory evoked Potentials is pronounced in migraine: an indication of cortical potentiation and low serotonergic neurotransmission? Neurology 1996; 46: 1404-9.
177. Hamel E. Serotonin and migraine: biology and clinical implications. Cephalalgia 2007; 27: 1295-1300.
178. Weiller C, May A, Limmroth, et al. Brain stem activation in spontaneous human migraine attacks. Nature Med 1995; 1: 658-60.
179. Emilien G, Maloteauw J-M, Geurts M, Hoogenberg K, Cragg S. Dopamine receptors physiological understanding to therapeutic intervention potential. Pharmacol Ther 1999; 84: 133-56.
180. Peroutka SJ. Dopamine and migraine. Neurology 1997; 49: 650-6.
181. Mascia A, Afra J, Schoenen J. Dopamine and migraine: a review of pharmacological, biochemical, neurophysiological, and therapeutic data. Cephalalgia 1998; 18: 174-82.
182. Vaccaro M, Riva C, Tremolizzo L, et al. Platelet glutamate uptake and release in migraine with and without aura. Cephalalgia 2007; 27: 35-40.
183. Kato T, Kato N. Mitochondrial dysfunction in bipolar disorder. Bipolar Disord 2000; 2: 180-90.
184. Welch KM, Ramadan NM. Mitochondria, magnesium and migraine. J Neurol Sci 1995; 134: 9-14.
185. Voss A, Baier V, Schulz S, Bar KJ. Linear and nonlinear methods for analyses of cardiovascular variability in bipolar disorders. Bipolar Disord 2006; 8: 441-52.
186. Yeragani VK. Major depression and long-term heart period variability. Depress Anxiety 2000; 12: 51-2.
187. Gorman JM, Sloan RP. Heart rate variability in depressive and anxiety disorders. Am Heart J 2000; 140: 577-83.
188. Groves DA, Brown VJ. Vagal nerve stimulation: a review of its applications and potential mechanisms that mediate its clinical effects. Neurosci Biobehav Rev 2005; 29: 493-500.
189. Milby AH, Halpern CH, Baltuch GH. Vagus nerve stimulation for epilepsy and depression. Neurotherapeutics 2008; 5: 75-85.
190. Avnon Y, Nitzan M, Sprecher E, Rogowski Z, Yarnitsky D. Autonomic asymmetry in migraine: augmented parasympathetic activation in left unilateral migraineurs. Brain 2004; 127: 2099-108.
191. Mosek A, Novak V, Opfer-Gehrking TL, Swanson JW, Low PA. Autonomic dysfunction in migraineurs. Headache 1999; 39: 108-17
192. Peroutka SJ. Migraine: a chronic sympathetic nervous system disorder. Headache 2004; 44: 53-64.
193. Lenaerts ME, Oommen KJ, Couch JR, Skaggs V. Can vagus nerve stimulation help migraine? Cephalalgia 2008; 28: 392-5.
194. Mravec B. Does the vagus nerve mediate the effects of polyunsaturated fatty acid treatment on behavioral, neuroendocrine and cytokine changes elicited by exogenous interleukin-1beta challenge? J Neuroimmunol 2007; 185: 208-10.
195. Tracey KJ. The inflammatory reflex. Nature 2002; 420: 853-9.
196. Hestad KA, Tønseth S, Støen CD, Ueland T, Aukrust P. Raised plasma levels of tumor necrosis factor alpha in patients with depression: normalization during electroconvulsive therapy. J ECT 2003; 19: 183-8.
197. Longoni M, Ferrarese C. Inflammation and excitotoxicity: role in migraine pathogenesis. Neurol Sci 2006; 27 (Suppl 2): S107-10.
198. Aurora SK, Wilkinson F. The brain is hyperexcitable in migraine. Cephalalgia 2007; 27: 1442-53.
199. Mulleners WM, Chronicle EP, Palmer JE, Koehler PJ, Vredeveld JW. Visual cortex excitability in migraine with and without aura. Headache 2001; 41: 565-72.
200. Wang W, TimsitBerthier M, Schoenen J. Intensity dependence of auditory evoked potentials in migraine: an indication of cortical potentiation and low serotonergic neurotransmission? Neurology 1996; 46: 1404-9.
201. Coppola G, Pierelli F, Schoenen J. Is the cerebral cortex hyperexcitable or hyperresponsive in migraine? Cephalalgia 2007; 27: 1427-39.
202. Silberstein SD. Migraine pathophysiology and its clinical implications. Cephalalgia 2004; 24 (Suppl 2): 2-7.
203. Aurora SK, Cao Y, Bowyer SM, Welch KM. The occipital cortex is hyperexcitable in migraine: experimental evidence. Headache 1999; 39: 469-76.
204. Iadecola C. From CSD to headache: a long and winding road. Nat Med 2002; 8: 110-2.
205. van den Maagdenberg AMJM, Haan J, Terwindt GM, Ferrari MD. Migraine: gene mutations and functional consequences. Curr Opin Neurol 2007; 20: 299-305.
206. Ramagopalan SV, Ramscar NE, Cader MZ. Molecular mechanisms of migraine? J Neurol 2007; 254: 1629-35.
207. Ayata C, Shimizu-Sasamata M, Lo EH, Noebels JL, Moskowitz MA. Impaired neurotransmitter release and elevated threshold for cortical spreading depression in mice with mutations in the alpha1A subunit of P/Q type calcium channels. Neuroscience 2000; 95: 639-45.
208. Goadsby PJ. Recent advances in understanding migraine mechanisms, molecules and therapeutics. Trends Mol Med 2007; 13: 39-44.
209. Denuelle M, Fabre N, Payoux P, Chollet F, Geraud G. Hypothalamic activation in spontaneous migraine attacks. Headache 2007; 47: 1418-26.
210. Stork C, Renshaw PF Mitochondrial dysfunction in bipolar disorder: evidence from magnetic resonance spectroscopy research. Mol Psychiatry 2005; 10: (10): 900-19.
211. Kato T, Kato N. Mitochondrial dysfunction in bipolar disorder. Bipolar Disord 2000; 2: 180-90.
212. Konradi C, Eaton M, MacDonald ML, Walsh J, Benes FM, Heckers S. Molecular evidence for mitochondrial dysfunction in bipolar disorder. Arch Gen Psychiatry 2004; 61: 300-8.
213. Barbiroli B, Montagna P, Cortelli P, et al. Abnormal brain and muscle energy metabolism shown by P magnetic resonance spectroscopy in patients affected by migraine with aura. Neurology 1992; 42: 1209-14.
214. Montagna P, Cortelli P, Monari L, et al. 31P-magnetic resonance spectroscopy in migraine without aura. Neurology 1994; 44: 666-9.
215. Schoenen J, Jacquy J, Lenaerts M. Effectiveness of high-dose riboflavin in migraine prophylaxis. A randomized controlled trial. Neurology 1998; 50: 466-70.
216. Sándor PS, Afra J, Ambrosini A, Schoenen J. Prophylactic treatment of migraine with beta-blockers and riboflavin: differential effects on the intensity dependence of auditory evoked cortical potentials. Headache 2000; 40: 30-5.
217. Coppen A, Shaw DM, Mangoni A. Total exchangeable sodium in depressive illness. Br Med J 1962; 2 (5300): 295-8.
218. Akiskal HS, McKinney WT Jr. Depressive disorders: toward a unified hypothesis. Science 1973; 182: 20-9.
219. Rose AM, Mellett BJ, Valdes R, Kleinman JE, Herman MED MER, Li R, El-Mallakh RS. Alpha2 isoform of the Na,K-adenosine triphosphatase is reduced in temporal cortex of bipolar individuals. Biol Psychiatry 1998; 44: 892-7.
220. El-Mallakh RS, El-Masri MA, Huff MO, Li XP, Decker S, Levy RS. Intracerebroventricular administration of ouabain as a model of mania in rats. Bipolar Disord 2003; 5: 362-5.
221. El-Mallakh RS, Wyatt RJ. The Na,K-ATPase hypothesis for bipolar illness. Biol Psychiatry 1995; 37: 235-44.
222. Huang X, Lei Z, El-Mallakh RS. Lithium normalizes elevated intracellular sodium. Bipolar Disord 2007; 9: 298-300.
223. Goldstein I, Levy T, Galili D, et al. Involvement of Na+, K+-ATPase and endogenous digitalis-like compounds in depressive disorders. Biol Psychiatry 2006; 60: 491-9.
224. Askland K, Parsons M. Toward a biaxial model of "bipolar" affective disorders: spectrum phenotypes as the products of neuroelectrical and neurochemical alterations. J Affect Disord 2006; 94: 15-33.
225. Kato T. Role of mitochondrial DNA in calcium signaling abnormality in bipolar disorder. Cell Calcium 2008; 44: 92-102.
226. Bremmer MA, Beekman AT, Deeg DJ, Penninx BW, Dik MG, Hack CE, Hoogendijk WJ. Inflammatory markers in late-life depression: results from a population-based study. J Affect Disord 2008; 106: 249-55.
227. Dickerson F, Stallings C, Origoni A, Boronow J, Yolken R. Elevated serum levels of C-reactive protein are associated with mania symptoms in outpatients with bipolar disorder. Prog Neuropsychopharmacol Biol Psychiatry 2007; 31: 952-5.
228. Marvel FA, Chen CC, Badr N, Gaykema RPA, Goehler LE. Reversible inactivation of the dorsal vagal complex blocks lipopolysaccharide-induced social withdrawal and c-Fos expression in central autonomic nuclei. Brain Behav Immun 2004; 18: 123-34.
229. Moskowitz MM. Genes, proteases, cortical spreading depression and migraine: impact on pathophysiology and treatment. Funct Neurol 2007; 22: 133-6.
230. Vanmolkot FH, de Hoon JN. Increased C-reactive protein in young adult patients with migraine. Cephalalgia 2007; 27: 843-6.
231. Ramadan NM, Schultz LL, Gilkey SJ. Migraine prophylactic drugs: proof of efficacy, utilization and cost. Cephalalgia 1997; 17: 73-80.
232. Silberstein SD. Comprehensive management of headache and depression. Cephalalgia 1998; 18 (Suppl 21): 50-5.
233. Adly C, Straumanis J, Chesson A. Fluoxetine prophylaxis of migraine. Headache 1992; 32: 101-4.
234. Ansari A. The efficacy of newer antidepressants in the treatment of chronic pain: a review of current literature. Harv Rev Psychiatry 2000; 7: 257-77.
235. Landy S, McGinnis J, Curlin D, Laizure SC. Selective serotonin reuptake inhibitors for migraine prophylaxis. Headache 1999; 39: 28-32.
236. Medina JL, Diamond S. Cyclical migraine. Arch Neurol 1981; 38: 343-4.
237. Peatfield RC, Clifford Rose F. Exacerbation of migraine by treatment with lithium. Headache 1981; 21: 140-2.
238. Post RM, Silberstein SD. Shared mechanisms in affective illness, epilepsy, and migraine. Neurology 1994; 44 (Suppl 7): S37-47.
239. Silberstein SD. Divalproex sodium in headache: literature review and clinical guidelines. Headache 1996; 36: 547-55.
240. Mathew NT, Saper JR, Silberstein SD, et al. Migraine prophylaxis with divalproex. Arch Neurol 1995; 52: 281-6.
241. Woodman CL, Noyes R Jr. Panic disorder: treatment with valproate. J Clin Psychiatry 1994; 55: 134-6.
242. Keck PE Jr, Taylor VE, Tugrul KC, McElroy SL, Bennett JA. Valproate treatment of panic disorder and lactate-induced panic attacks. Biol Psychiatry 1993; 33: 542-6.
243. Freeman MP, Freeman SA, McElroy SL. The comorbidity of bipolar and anxiety disorders: prevalence, psychobiology, and treatment issues. J Affect Disord 2002; 68: 1-23.
244. Blier P, Bergeron R, The safety of concomitant use of sumatriptan and antidepressant treatments. J Clin Psychopharmacol 1995; 15: 106-9.
245. Millson D, Frischer M, Croft P, Goadsby PJ. Are triptans with enhanced lipophilicity used for the acute treatment of migraine associated with an increased consulting rate for depressive illness? Cephalalgia 2000; 20: 732-7.
246. Mathew NT, Tietjen GE, Lucker C. Serotonin syndrome complicating migraine pharmacotherapy. Cephalalgia 1996; 16: 323-7.
247. Joffe RT, Sokolov ST. Co-administration of fluoxetine and sumatriptan: the Canadian experience. Acta Psychiatr Scand 1997; 95: 551-2.
248. Gardner DM, Lynd LD. Sumatriptan contraindications and the serotonin syndrome. Ann Pharmacother 1998; 32: 33-8.
249. Gleiter CH, Deckert J. Adverse CNS-effects of beta-adrenoceptor blockers. Pharmacopsychiatry 1996; 29: 201-11.
250. Ko DT, Hebert PR, Coffey CS, Sedrakyan A, Curtis JP, Krumholz HM. β-blocker therapy and symptoms of depression, fatigue, and sexual dysfunction. JAMA 2002; 288: 351-7.